secwatch.observer — SEC 8-K summary
======================================

Issuer:     Co-Diagnostics, Inc. (CODX)
CIK:        0001692415
Form:       8-K
Filed at:   2025-09-18T23:59:59+00:00
Accession:  0001493152-25-013981
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Co-Diagnostics announces $3.8M registered direct offering of 9.62M shares at $0.40/share
--------------------------------------------------------------------------------

- Sold 9,619,000 common shares at $0.40/share in registered direct offering to institutional investors.
- Gross proceeds $3.8M; net after 7% placement agent fee and expenses; use for working capital.
- Maxim Group LLC is sole placement agent; closing expected Sept 18, 2025.
- Investors get participation rights in up to 30% of future financings within 12 months.
- Offering priced at-the-market under Nasdaq rules; customary 30-day lock-up on new issuances.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1692415/000149315225013981/0001493152-25-013981-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1692415/000149315225013981/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-013981

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer